Comey C T, Budowle B, Adams D E, Baumstark A L, Lindsey J A, Presley L A
Forensic Science Research and Training Center, FBI Academy, Quantico, VA.
J Forensic Sci. 1993 Mar;38(2):239-49.
The polymerase chain reaction (PCR) was used to amplify the HLA DQ alpha gene using DNA recovered from evidentiary samples. Amplified HLA DQ alpha DNA was then typed using sequence-specific oligonucleotide probes. Slight modifications of previously published DNA extraction methods improved typing success of bloodstains and semen-containing material. Evidentiary samples, consisting of 206 known bloodstains, 26 questioned bloodstains, and 123 questioned semen-containing evidentiary materials were analyzed from 96 cases previously analyzed by restriction fragment length polymorphism (RFLP) typing in the FBI Laboratory. Of the known bloodstains, 98.5% yielded DQ alpha typing results. Of the questioned samples, 102 of 149 (24/26 bloodstains and 78/123 semen-containing materials), or 68%, produced typing results. Of the 78 cases that were RFLP inclusions, 59 yielded interpretable DQ alpha results and these were all inclusions. The remaining 19 cases could not be interpreted for DQ alpha. Of the 18 RFLP exclusions, eleven were DQ alpha exclusions, four were DQ alpha inclusions, and three could not be interpreted for DQ alpha. It is expected that because of the difference in discrimination potential of the two methods, some RFLP exclusions would be DQ alpha inclusions. Some samples that failed to produce typing results may have had insufficient DNA for analysis. Employment of a human DNA quantification method in DQ alpha casework would allow the user to more consistently use sufficient quantities of DNA for amplification. It also could provide a guide for determining if an inhibitor of PCR is present, thus suggesting the use of a procedure to improve amplification. This study provides support that the HLA DQ alpha typing procedure is valid for typing forensic samples.
聚合酶链反应(PCR)用于使用从证据样本中提取的DNA扩增HLA DQα基因。然后使用序列特异性寡核苷酸探针对扩增的HLA DQα DNA进行分型。对先前发表的DNA提取方法进行轻微修改后,提高了血迹和含精液物质的分型成功率。对联邦调查局实验室先前通过限制性片段长度多态性(RFLP)分型分析的96起案件中的206份已知血迹、26份可疑血迹和123份可疑含精液证据材料进行了分析。在已知血迹中,98.5%获得了DQα分型结果。在可疑样本中,149份中的102份(24份血迹和78份含精液物质),即68%,产生了分型结果。在78例RFLP包含的案件中,59例获得了可解释的DQα结果,且这些均为包含结果。其余19例无法对DQα进行解释。在18例RFLP排除的案件中,11例为DQα排除,4例为DQα包含,3例无法对DQα进行解释。由于两种方法在鉴别潜力上存在差异,预计一些RFLP排除的案件会是DQα包含的情况。一些未能产生分型结果的样本可能DNA量不足,无法进行分析。在DQα案件工作中采用人类DNA定量方法将使使用者能够更一致地使用足够量的DNA进行扩增。它还可以为确定是否存在PCR抑制剂提供指导,从而提示使用改进扩增的程序。本研究支持HLA DQα分型程序对法医样本分型是有效的。